// App-Quantinova.ai

2865 : The Cellular Effects of ANTI-Factor Xa Antibodies Isolated from Patients with Antiphospholipid Syndrome ARE Inhibited By Factorxa Inhibitors, Hydroxychloroquine and Fluvastatin

Researchers

Presenter

  • Bahar Artim-Esen

Principal Investigators

  • Natalia Smoktunowicz

  • Vera M. Ripoll

  • Charis Pericleous

  • Rachel Chambers

  • Ian Mackie

  • David Isenberg

  • Anisur Rahman

  • Yiannis Ioannou

  • Ian Giles

Medical Centers

  • Adolescent Centre for Rheumatology Research, University College London, London, United Kingdom

  • Rayne Institute, st floor, Respiratory Research Unit, University College London, London, United Kingdom

  • Centre for Rheumatology, Rayne Institute, th floor, Centre for Rheumatology, University College London, London, United Kingdom

  • Haemostasis Research Unit, st Floor, Chenies Mews, Haemostasis Research Unit, University College London, London, United Kingdom

  • Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom

  • Department of Internal Medicine, Division of Rheumatology, Rheumatology Division, Department of Internal Medicine, Istanbul Faculty of Medicine,Istanbul University, Istanbul, Turkey

  • Adolescent Centre for Rheumatology Research, University College London, London, United Kingdom

Locations

  • Turkey

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Fluvastatin

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved